Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy

Background: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains uncl...

Full description

Bibliographic Details
Main Authors: Sandra Carpinelli, Philipp O. Valko, Daniel Waldvogel, Elena Buffone, Christian R. Baumann, Dominik Straumann, Esther Werth, Christopher J. Bockisch, Konrad P. Weber, Yulia Valko
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/full
id doaj-a7c6f85eb33c42178c849896e012b5ca
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Sandra Carpinelli
Philipp O. Valko
Philipp O. Valko
Daniel Waldvogel
Elena Buffone
Christian R. Baumann
Christian R. Baumann
Dominik Straumann
Esther Werth
Esther Werth
Christopher J. Bockisch
Christopher J. Bockisch
Christopher J. Bockisch
Konrad P. Weber
Konrad P. Weber
Yulia Valko
Yulia Valko
spellingShingle Sandra Carpinelli
Philipp O. Valko
Philipp O. Valko
Daniel Waldvogel
Elena Buffone
Christian R. Baumann
Christian R. Baumann
Dominik Straumann
Esther Werth
Esther Werth
Christopher J. Bockisch
Christopher J. Bockisch
Christopher J. Bockisch
Konrad P. Weber
Konrad P. Weber
Yulia Valko
Yulia Valko
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
Frontiers in Neurology
vestibular evoked myogenic potentials
oVEMP
cVEMP
Parkinson disease
progressive supranuclear palsy
author_facet Sandra Carpinelli
Philipp O. Valko
Philipp O. Valko
Daniel Waldvogel
Elena Buffone
Christian R. Baumann
Christian R. Baumann
Dominik Straumann
Esther Werth
Esther Werth
Christopher J. Bockisch
Christopher J. Bockisch
Christopher J. Bockisch
Konrad P. Weber
Konrad P. Weber
Yulia Valko
Yulia Valko
author_sort Sandra Carpinelli
title Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
title_short Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
title_full Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
title_fullStr Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
title_full_unstemmed Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
title_sort distinct vestibular evoked myogenic potentials in patients with parkinson disease and progressive supranuclear palsy
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-02-01
description Background: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains unclear whether ocular and cervical VEMPs differ between PD and PSP patients.Methods: We prospectively included 12 PD and 11 PSP patients, performed ocular and cervical VEMPs, and calculated specific VEMP scores (0 = normal, 12 = most pathological) based on latencies, amplitude, and absent responses. In addition, we assessed disease duration, presence of imbalance, motor asymmetry, and motor disability using the Movement Disorder Society Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III). Moreover, we ascertained various sleep parameters by video-polysomnography.Results: PSP and PD patients had similar oVEMP scores (6 [3–6] vs. 3 [1.3–6], p = 0.06), but PSP patients had higher cVEMP scores (3 [0–6] vs. 0 [0–2.8], p = 0.03) and total VEMP scores (9 [5–12] vs. 4 [2–7.5], p = 0.01). Moreover, total VEMP scores >10 were only observed in PSP patients (45%, p = 0.01). MDS-UPDRS III correlated with cVEMP scores (rho = 0.77, p = 0.01) in PSP, but not in PD. In PD, but not in PSP, polysomnographic markers of disturbed sleep, including decreased rapid eye movement sleep, showed significant correlations with VEMP scores.Conclusions: Our findings suggest that central vestibular pathways are more severely damaged in PSP than in PD, as indicated by higher cervical and total VEMP scores in PSP than PD in a between-groups analysis. Meaningful correlations between VEMPs and motor and non-motor symptoms further encourage its use in neurodegenerative Parkinsonian syndromes.
topic vestibular evoked myogenic potentials
oVEMP
cVEMP
Parkinson disease
progressive supranuclear palsy
url https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/full
work_keys_str_mv AT sandracarpinelli distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT philippovalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT philippovalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT danielwaldvogel distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT elenabuffone distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT christianrbaumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT christianrbaumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT dominikstraumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT estherwerth distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT estherwerth distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT konradpweber distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT konradpweber distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT yuliavalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
AT yuliavalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy
_version_ 1724273766525042688
spelling doaj-a7c6f85eb33c42178c849896e012b5ca2021-02-12T04:44:23ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-02-011110.3389/fneur.2020.598763598763Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear PalsySandra Carpinelli0Philipp O. Valko1Philipp O. Valko2Daniel Waldvogel3Elena Buffone4Christian R. Baumann5Christian R. Baumann6Dominik Straumann7Esther Werth8Esther Werth9Christopher J. Bockisch10Christopher J. Bockisch11Christopher J. Bockisch12Konrad P. Weber13Konrad P. Weber14Yulia Valko15Yulia Valko16Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandBackground: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains unclear whether ocular and cervical VEMPs differ between PD and PSP patients.Methods: We prospectively included 12 PD and 11 PSP patients, performed ocular and cervical VEMPs, and calculated specific VEMP scores (0 = normal, 12 = most pathological) based on latencies, amplitude, and absent responses. In addition, we assessed disease duration, presence of imbalance, motor asymmetry, and motor disability using the Movement Disorder Society Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III). Moreover, we ascertained various sleep parameters by video-polysomnography.Results: PSP and PD patients had similar oVEMP scores (6 [3–6] vs. 3 [1.3–6], p = 0.06), but PSP patients had higher cVEMP scores (3 [0–6] vs. 0 [0–2.8], p = 0.03) and total VEMP scores (9 [5–12] vs. 4 [2–7.5], p = 0.01). Moreover, total VEMP scores >10 were only observed in PSP patients (45%, p = 0.01). MDS-UPDRS III correlated with cVEMP scores (rho = 0.77, p = 0.01) in PSP, but not in PD. In PD, but not in PSP, polysomnographic markers of disturbed sleep, including decreased rapid eye movement sleep, showed significant correlations with VEMP scores.Conclusions: Our findings suggest that central vestibular pathways are more severely damaged in PSP than in PD, as indicated by higher cervical and total VEMP scores in PSP than PD in a between-groups analysis. Meaningful correlations between VEMPs and motor and non-motor symptoms further encourage its use in neurodegenerative Parkinsonian syndromes.https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/fullvestibular evoked myogenic potentialsoVEMPcVEMPParkinson diseaseprogressive supranuclear palsy